AAAAAA

   
Results: 1-9 |
Results: 9
Medullary thyroid carcinoma: role of genetic testing and calcitonin measurement
Authors: Lips, CJM Hoppener, JWM Thijssen, JHH
Citation: Cjm. Lips et al., Medullary thyroid carcinoma: role of genetic testing and calcitonin measurement, ANN CLIN BI, 38, 2001, pp. 168-179
Internally shortened menin protein as a consequence of alternative RNA splicing due to a germline deletion in the multiple endocrine neoplasia type 1gene
Authors: Roijers, JFM Apel, T Neumann, HPH Arnim, UV Lips, CJM Hoppener, JWM
Citation: Jfm. Roijers et al., Internally shortened menin protein as a consequence of alternative RNA splicing due to a germline deletion in the multiple endocrine neoplasia type 1gene, INT J MOL M, 5(6), 2000, pp. 611-614
Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice
Authors: Acton, DS Velthuyzen, D Lips, CJM Hoppener, JWM
Citation: Ds. Acton et al., Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice, ONCOGENE, 19(27), 2000, pp. 3121-3125
Pseudohypoparathyroidism type Ia - Albright hereditary osteodystrophy: a model for research on G protein-coupled receptors and genomic imprinting
Authors: Simon, A Koppeschaar, HPF Roijers, JFM Hoppener, JWM Lips, CJM
Citation: A. Simon et al., Pseudohypoparathyroidism type Ia - Albright hereditary osteodystrophy: a model for research on G protein-coupled receptors and genomic imprinting, NETH J MED, 56(3), 2000, pp. 100-109
Islet amyloid and type 2 diabetes mellitus
Authors: Hoppener, JWM Ahren, B Lips, CJM
Citation: Jwm. Hoppener et al., Islet amyloid and type 2 diabetes mellitus, N ENG J MED, 343(6), 2000, pp. 411-419
Criteria for mutation analysis in MEN 1-suspected patients: MEN 1 case-finding
Authors: Roijers, JFM de Wit, MJ van der Luijt, RB van Amstel, HKP Hoppener, JWM Lips, CJM
Citation: Jfm. Roijers et al., Criteria for mutation analysis in MEN 1-suspected patients: MEN 1 case-finding, EUR J CL IN, 30(6), 2000, pp. 487-492
Islet amyloid polypeptide amylin messenger RNA and protein expression in human insulinomas in relation to amyloid formation
Authors: van Hulst, KL Oosterwijk, C Born, W Vroom, TM Nieuwenhuis, MG Blankenstein, MA Lips, CJM Fischer, JA Hoppener, JWM
Citation: Kl. Van Hulst et al., Islet amyloid polypeptide amylin messenger RNA and protein expression in human insulinomas in relation to amyloid formation, EUR J ENDOC, 140(1), 1999, pp. 69-78
Management of renal cell carcinoma in von Hippel-Lindau disease
Authors: Hes, FJ Slootweg, PJ van Vroonhoven, TJMV Hene, RJ Feldberg, MAM Zewald, RA van Amstel, JKP Hoppener, JWM Pearson, PL Lips, CJM
Citation: Fj. Hes et al., Management of renal cell carcinoma in von Hippel-Lindau disease, EUR J CL IN, 29(1), 1999, pp. 68-75
Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: pathogenesis of diabetesin a mouse model
Authors: Hoppener, JWM Oosterwijk, C Nieuwenhuis, MG Posthuma, G Thijssen, JHH Vroom, TM Ahren, B Lips, CJM
Citation: Jwm. Hoppener et al., Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: pathogenesis of diabetesin a mouse model, DIABETOLOG, 42(4), 1999, pp. 427-434
Risultati: 1-9 |